信息助推提高流感疫苗接种:芬兰大规模整群随机对照试验证据
在芬兰两个文化与地理上不同的地区,对全部65岁及以上老年人开展整群随机对照试验,比较集中书面提醒(个体获益提醒、个体与社会获益提醒)与无提醒对流感疫苗接种率的影响。结果显示,任何类型提醒信使接种率提高6.4个百分点(95%CI 3.6–9.1,P<0.001),在既往未接种者中效果更大(8.8个百分点),但个体获益提醒与个体及社会获益提醒之间无显著差异。
要点
- 在历史接种率低的地区,任何提醒信使流感疫苗接种率较无提醒提高6.4个百分点(95%CI 3.6–9.1,P<0.001)。
- 在既往9年未接种任何疫苗者中,提醒信使接种率提高5.3个百分点(95%CI 2.8–7.8,P<0.001)。
- 个体获益提醒与个体及社会获益提醒之间接种率无显著差异。
核心结论
- 在接种率低的老年人群中,寄送提醒信是提高流感疫苗接种率的有效且可扩展的干预策略。
- 在个体获益之外传达社会获益并未提高接种率。
- 提醒信提高流感疫苗接种率的效果可能取决于人群既往接种史。
研究设计与样本
- 在芬兰两个文化与地理上不同地区开展大规模整群随机对照试验,纳入全部65岁及以上老年人。
- 历史接种率低的地区:接种率31.8%,n=7,398,平均年龄75.5岁;历史接种率高的地区:接种率57.7%,n=40,727,平均年龄74.0岁。
- 研究人群随机分为3组:无提醒(仅低接种率地区)、个体获益提醒、个体与社会获益提醒。
- 高接种率地区无对照组,因往年已寄送通用提醒。
- 主要终点为5个月随访期(2018年10月18日至2019年3月18日)内芬兰国家疫苗接种登记中的流感疫苗接种记录。
主要发现
- 低接种率地区干预后接种率:个体获益提醒组41.8%,个体与社会获益提醒组38.9%,对照组34.0%。
- 高接种率地区干预后接种率:个体获益提醒组59.0%,个体与社会获益提醒组59.2%。
- 任何类型提醒信较无提醒的效应为6.4个百分点(95%CI 3.6–9.1,P<0.001)。
- 既往未接种流感疫苗者中效应为8.8个百分点(95%CI 6.5–11.1,P<0.001);研究前9年未接种任何疫苗者中效应为5.3个百分点(95%CI 2.8–7.8,P<0.001)。
- 个体获益提醒与个体及社会获益提醒比较:低接种率地区差异2.9个百分点(95%CI -0.4–6.1,P=0.087),高接种率地区差异0.2个百分点(95%CI -1.0–1.3,P=0.724)。
临床怎么用
- 原文结论指出寄送提醒信是提高低接种率老年人群流感疫苗接种率的有效且可扩展干预策略。
- 原文结论指出在个体获益之外传达社会获益并未提高接种率。
局限性
- 研究局限性包括干预组间可能因信息溢出而存在污染。
- 高接种率地区缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccination is the most effective means of preventing the spread of infectious diseases. Despite the proven benefits of vaccination, vaccine hesitancy keeps many people from getting vaccinated. METHODS AND FINDINGS: We conducted a large-scale cluster randomized controlled trial in Finland to test the effectiveness of centralized written reminders (distributed via mail) on influenza vaccination coverage. The study included the entire older adult population (aged 65 years and above) in 2 culturally and geographically distinct regions with historically low (31.8%, n = 7,398, mean age 75.5 years) and high (57.7%, n = 40,727, mean age 74.0 years) influenza vaccination coverage. The study population was randomized into 3 treatments: (i) no reminder (only in the region with low vaccination coverage); (ii) an individual-benefits reminder, informing recipients about the individual benefits of vaccination; and (iii) an individual- and social-benefits reminder, informing recipients about the additional social benefits of vaccination in the form of herd immunity. There was no control treatment group in the region with high vaccination coverage as general reminders had been sent in previous years. The primary endpoint was a record of influenza vaccination in the Finnish National Vaccination Register during a 5-month follow-up period (from October 18, 2018 to March 18, 2019). Vaccination coverage after the intervention in the region with historically low coverage was 41.8% in the individual-benefits treatment, 38.9% in the individual- and social-benefits treatment and 34.0% in the control treatment group. Vaccination coverage after the intervention in the region with historically high coverage was 59.0% in the individual-benefits treatment and 59.2% in the individual- and social-benefits treatment. The effect of receiving any type of reminder letter in comparison to control treatment group (no reminder) was 6.4 percentage points (95% CI: 3.6 to 9.1, p < 0.001). The effect of reminders was particularly large among individuals with no prior influenza vaccination (8.8 pp, 95% CI: 6.5 to 11.1, p < 0.001). There was a substantial positive effect (5.3 pp, 95% CI: 2.8 to 7.8, p < 0.001) among the most consistently unvaccinated individuals who had not received any type of vaccine during the 9 years prior to the study. There was no difference in influenza vaccination coverage between the individual-benefit reminder and the individual- and social-benefit reminder (region with low vaccination coverage: 2.9 pp, 95% CI: -0.4 to 6.1, p = 0.087, region with high vaccination coverage: 0.2 pp, 95% CI: -1.0 to 1.3, p = 0.724). Study limitations included potential contamination between the treatments due to information spillovers and the lack of control treatment group in the region with high vaccination coverage. CONCLUSIONS: In this study, we found that sending reminders was an effective and scalable intervention strategy to increase vaccination coverage in an older adult population with low vaccination coverage. Communicating the social benefits of vaccinations, in addition to individual benefits, did not enhance vaccination coverage. The effectiveness of letter reminders about the benefits of vaccination to improve influenza vaccination coverage may depend on the prior vaccination history of the population. TRIAL REGISTRATION: AEA RCT registry AEARCTR-0003520 and ClinicalTrials.gov NCT03748160.
引用
- Sääksvuori L, Betsch C, Nohynek H, et al. Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland. PLoS Med. 2022. PMID: 35139082. doi:10.1371/journal.pmed.1003919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。